Combination therapy of a type II anti-CD20 antibody with an anti-Bcl-2 active agent
- 专利权人:
- 发明人:
- 申请号:
- EP13155433.9
- 公开号:
- EP2604277A1
- 申请日:
- 2008.10.13
- 申请国别(地区):
- EP
- 年份:
- 2013
- 代理人:
- 摘要:
- The present invention is directed to the use of a type II anti-CD20 antibody for the manufacture of a medicament for the treatment of cancer, especially of CD20 expressing cancers in combination with an anti-Bcl-2 active agent.
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- Combination therapy of a type II anti-CD20 antibody with an anti-Bcl-2 active agent
- COMBINATION THERAPY FOR THE TREATMENT OF CANCER
- Combination Therapy for the Treatment of Cancer
- COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH INCREASED ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY (ADCC)
- Combination Therapy For Treating Cancer